Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 7/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.37 |
| ▸ | REN | P00797 | 4/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL762453 | 0.88 | HRH1 (0.39) | HRH1KCNH2CYP2D6CHRM1REN | |
| Ammonia Solution, Strong SCHEMBL741029 | 0.87 | HRH1 (0.39) | HRH1KCNH2CYP2D6CHRM1REN | |
| SCHEMBL742178 | 0.79 | KCNH2 (0.44) | HRH1KCNH2CYP2D6CHRM1REN | |
| SCHEMBL742177 | 0.79 | KCNH2 (0.44) | HRH1KCNH2CYP2D6CHRM1REN | |
| SCHEMBL740703 | 0.78 | ALDH1A1 (0.33) | RENBRD4POLB | |
| SCHEMBL742179 | 0.78 | HRH1 (0.44) | HRH1KCNH2CYP2D6CHRM1USP2 | |
| Hydrochloric Acid SCHEMBL15013604 | 0.77 | REN (0.40) | HRH1KCNH2CYP2D6CHRM1REN | |
| SCHEMBL763016 | 0.75 | MMP7 (0.41) | HRH1KCNH2CYP2D6CHRM1 | |
| Hydrochloric Acid SCHEMBL743077 | 0.74 | KCNH2 (0.44) | HRH1KCNH2CYP2D6CHRM1USP2 | |
| Hydrochloric Acid SCHEMBL743078 | 0.74 | KCNH2 (0.44) | HRH1KCNH2CYP2D6CHRM1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138168-B1 | Renin inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-03-20 | — | — | US | disclosed |